The Florida Senate

499.01211  Drug Wholesaler Advisory Council.--

(1)  There is created the Drug Wholesaler Advisory Council within the department. The council shall meet at least once each calendar quarter. Staff for the council shall be provided by the department. The council shall consist of 11 members who shall serve without compensation. The council shall elect a chairperson and a vice chairperson annually.

(2)  The secretary of the department, or his or her designee, and the Secretary of Health Care Administration, or her or his designee, shall be members of the council. The Secretary of Health shall appoint nine additional members to the council who shall be appointed to a term of 4 years each, as follows:

(a)  Three different persons each of whom is employed by a different prescription drug wholesaler licensed under this chapter which operates nationally and is a primary wholesaler, as defined in s. 499.012(1)(d).

(b)  One person employed by a prescription drug wholesaler licensed under this chapter which is a secondary wholesaler, as defined in s. 499.012(1)(f).

(c)  One person employed by a retail pharmacy chain located in this state.

(d)  One person who is a member of the Board of Pharmacy and is a pharmacist licensed under chapter 465.

(e)  One person who is a physician licensed pursuant to chapter 458 or chapter 459.

(f)  One person who is an employee of a hospital licensed pursuant to chapter 395 and is a pharmacist licensed pursuant to chapter 465.

(g)  One person who is an employee of a pharmaceutical manufacturer.

(3)  The council shall review ss. 499.001-499.081 and the rules adopted to administer ss. 499.001-499.081 annually, provide input to the department regarding all proposed rules to administer ss. 499.001-499.081, make written recommendation to the secretary of the department regarding the listing of all specified drugs pursuant to s. 499.0121(6)(e), make recommendations to the department to improve the protection of the prescription drugs and public health, make recommendations to improve coordination with other states' regulatory agencies and the federal government concerning the wholesale distribution of drugs, and make recommendations to minimize the impact of regulation of the wholesale distribution industry while ensuring protection of the public health.

History.--s. 17, ch. 2003-155.